SaniSure Completes State-of-the-Art Extractables and Biocompatibility Testing For Multiple Product Lines

CAMARILLO, Calif.: CAMARILLO, Calif., Sept. 28, 2021 /PRNewswire/ -- SaniSure, a global developer and manufacturer of single-use technology for the biopharmaceutical industry, announces the completion of a comprehensive extractables and biocompatibility study for many key products commonly used in biopharma manufacturing and development. SaniSure contracted with The BioProcess Institute to...

Click to view original post